Sign in
Download Opera News App

DISEASE PREVENTION AND TREATMENT

Actinium Says DMC Recommends Phase 3 SIERRA Trial Continue To Full Enrolment Of 150 Patients

Actinium Says DMC Recommends Phase 3 SIERRA Trial Continue To Full Enrolment Of 150 Patients

Actinium Pharmaceuticals, Inc. (ATNM) said Tuesday that the independent Data Monitoring Committee or DMC has completed the single ad hoc interim analysis of the pivotal Phase 3 SIERRA study of Iomab-B for bone marrow transplant (BMT) conditioning in patients aged above 55 with active relapsed or refractory Acute Myeloid Leukemia...

Read Full Story
Actinium BMT DMC Data Monitoring Committee Iomab-B SIERRA

Top News

US POLITICS

Liberals on fire over failure on $15 minimum wage

thehill.com
Liberals on fire over failure on $15 minimum wage

US POLITICS

Liberals on fire over failure on $15 minimum wage

thehill.com

US POLITICS

'Lucky': Biden was at first reluctant to apologize for touching allegation

thehill.com
'Lucky': Biden was at first reluctant to apologize for touching allegation

US POLITICS

'Lucky': Biden was at first reluctant to apologize for touching allegation

thehill.com